Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
9.05
+0.16 (1.86%)
Jun 29, 2026, 11:30 AM EDT - Market open
Novavax Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 596.34 | 1,123 | 682.16 | 983.71 | 1,982 | 1,146 | |
Revenue Growth (YoY) | -52.48% | 64.69% | -30.65% | -50.37% | 72.89% | 141.02% |
Cost of Revenue | 89.62 | 73.04 | 202.74 | 343.77 | 902.64 | - |
Gross Profit | 506.72 | 1,050 | 479.42 | 639.94 | 1,079 | 1,146 |
Selling, General & Admin | 138.17 | 157.48 | 337.19 | 468.95 | 488.69 | 298.36 |
Research & Development | 348.86 | 342.32 | 391.17 | 737.5 | 1,235 | 2,535 |
Other Operating Expenses | - | 97.85 | - | - | - | - |
Total Operating Expenses | 487.02 | 597.64 | 728.35 | 1,206 | 1,724 | 2,833 |
Operating Income | -78.15 | 452.8 | -248.93 | -566.51 | -644.74 | -1,687 |
Interest Expense | -21.73 | -22.55 | -20.08 | -14.42 | -19.88 | -21.13 |
Other Non-Operating Income (Expense) | 42.4 | 11.92 | 92.39 | 37.9 | 10.97 | -6.83 |
Total Non-Operating Income (Expense) | 20.68 | -10.63 | 72.32 | 23.48 | -8.91 | -27.96 |
Pretax Income | -86.19 | 442.17 | -176.62 | -543.03 | -653.65 | -1,715 |
Provision for Income Taxes | -2.08 | -1.87 | -10.88 | -2.03 | -4.29 | -29.22 |
Net Income | -87.84 | 440.3 | -187.5 | -545.06 | -657.94 | -1,744 |
Net Income to Common | -87.84 | 440.3 | -187.5 | -545.06 | -657.94 | -1,744 |
Shares Outstanding (Basic) | 163 | 162 | 152 | 101 | 78 | 74 |
Shares Outstanding (Diluted) | 167 | 173 | 152 | 101 | 78 | 74 |
Shares Change (YoY) | 0.64% | 13.74% | 51.03% | 28.89% | 5.08% | 29.27% |
EPS (Basic) | -0.54 | 2.72 | -1.23 | -5.41 | -8.42 | -23.44 |
EPS (Diluted) | -0.58 | 2.58 | -1.23 | -5.41 | -8.42 | -23.44 |
Free Cash Flow | -97.65 | -250.2 | -100.32 | -767.74 | -504.99 | 268.45 |
Free Cash Flow Per Share | -0.58 | -1.45 | -0.66 | -7.62 | -6.46 | 3.61 |
Gross Margin | 84.97% | 93.50% | 70.28% | 65.05% | 54.46% | 100.00% |
Operating Margin | -13.10% | 40.30% | -36.49% | -57.59% | -32.53% | -147.13% |
Profit Margin | -14.73% | 39.19% | -27.49% | -55.41% | -33.20% | -152.12% |
FCF Margin | -16.38% | -22.27% | -14.71% | -78.05% | -25.48% | 23.42% |
EBITDA | -55.81 | 480.41 | -200.44 | -525.29 | -615.68 | -1,674 |
EBITDA Margin | -9.36% | 42.76% | -29.38% | -53.40% | -31.07% | -146.03% |
EBIT | -78.15 | 452.8 | -248.93 | -566.51 | -644.74 | -1,687 |
EBIT Margin | -13.10% | 40.30% | -36.49% | -57.59% | -32.53% | -147.13% |
Effective Tax Rate | 2.41% | -0.42% | 6.16% | 0.37% | 0.66% | 1.70% |